While Phase 1 study records exist, peer-reviewed large-scale safety data is lacking
Its primary mechanism is angiogenesis: BPC-157 triggers new blood vessel growth (via VEGF upregulation) in injured tissue, which accelerates tendon, ligament, gut, and joint repair
Others (MOTS-c, SS-31, Tesamoerlin, Sermorelin) peptides benefit from using NaCl BAC to reduce injection site reactions, and acidic compounds such as NAD+ are best bought as a buffered version and reconstituted with NaCl BAC
This decline in NAD+ levels makes it harder for us to fix cellular damage and can "turn off" genes that speed up degenerative aging
It has been evaluated in clinical and preclinical models for its ability to modulate dopamine, norepinephrine, and serotonin signaling pathways associated with metabolic and neurological research.
Stacy M.